Internal Medicine · Ridgewood, NY
NPI
1912907742
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
5629 Metropolitan Ave
Ridgewood, NY, 11385
Phone (718) 418-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$115K
1,962 services
Medicare patients, 2024
252
Average age 78
Drug cost, 2024
$3.8M
18,297 prescriptions
Company payments, 2025
$2,488
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stella Ilyaev was code 99213 (office e&m - established), 599 times for 199 patients. In total Stella Ilyaev billed 1,962 services in 61 codes, and Medicare paid $115K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 599 | 199 | $70.63 | $42K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 167 | 62 | $0.96 | $160 |
| 96372 Injection Administration | Office | 110 | 49 | $11.62 | $1,278 |
| 96365 Intravenous Infusion, Hydration | Office | 86 | 35 | $51.97 | $4,469 |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 79 | 32 | $0.97 | $76.42 |
| 99497 Care Management/Coordination | Office | 77 | 76 | $85.25 | $6,564 |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 75 | 31 | $0.46 | $34.76 |
| 99212 Office E&M - Established | Office | 68 | 46 | $46.77 | $3,180 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 67 | 67 | $142.38 | $9,539 |
| 82962 Clinical Chemistry | Office | 63 | 23 | $3.21 | $202 |
| 36415 Venipuncture Blood Collection | Office | 35 | 29 | $5.02 | $176 |
| 99214 Office E&M - Established | Office | 34 | 29 | $106.21 | $3,611 |
| G0008 Administration of influenza virus vaccine | Office | 22 | 22 | $37.03 | $815 |
| 90662 Vaccine Product | Office | 19 | 19 | $81.82 | $1,555 |
| 93000 Electrocardiogram | Office | 17 | 15 | $11.33 | $193 |
By year: 2022 $143K for 3,058 services; 2023 $110K for 2,262 services; 2024 $115K for 1,962 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 63 | 23 | $3.21 | $202 |
| 36415 Venipuncture Blood Collection | 35 | 29 | $5.02 | $176 |
Medicare prescription drug claims, 2024
In 2024, the drug Stella Ilyaev prescribed most often to Medicare patients was Amlodipine Besylate, with 681 prescriptions and refills. In total Stella Ilyaev wrote 18,297 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 681 | 875 | 107 | $3,408 |
| Rosuvastatin Calcium Generic | 518 | 703 | 98 | $15K |
| Vascepa Icosapent Ethyl | 513 | 539 | 76 | $184K |
| Metoprolol Succinate Generic | 480 | 624 | 83 | $6,754 |
| Atorvastatin Calcium Generic | 403 | 595 | 80 | $4,404 |
| Omeprazole Generic | 399 | 487 | 69 | $3,568 |
| Synthroid Levothyroxine Sodium | 385 | 461 | 54 | $22K |
| Linzess Linaclotide | 355 | 378 | 64 | $198K |
| Diclofenac Sodium Generic | 339 | 347 | 84 | $157K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 331 | 379 | 55 | $1,035 |
| Losartan Potassium Generic | 321 | 442 | 59 | $2,595 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 296 | 296 | 48 | $7,944 |
| Metformin Hcl Generic | 271 | 315 | 50 | $1,679 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 263 | 387 | 46 | $4,614 |
| Janumet Sitagliptin Phos/Metformin Hcl | 258 | 284 | 37 | $157K |
Brand drugs: 5,636 claims; generic drugs: 12,068 claims; opioid claims: 476.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stella Ilyaev $2,488 ($2,488 in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $342.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 17 | $342 |
| Abbvie Inc. ABBV | 8 | $237 |
| GlaxoSmithKline, LLC. GSK | 12 | $212 |
| Dexcom, Inc. DXCM | 3 | $180 |
| Axsome Therapeutics, Inc. AXSM | 3 | $169 |
| Amgen Inc. AMGN | 11 | $166 |
| Pfizer Inc. PFE | 10 | $160 |
| Biogen, Inc. BIIB | 6 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $127 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 6 | $104 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.